Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy
- 29 February 2008
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 121 (2) , 390-395
- https://doi.org/10.1016/j.jaci.2007.09.026
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthmaJournal of Allergy and Clinical Immunology, 2006
- Angiopoietin-2: Modulator of Vascular Permeability in Acute Lung Injury?PLoS Medicine, 2006
- Excess Circulating Angiopoietin-2 May Contribute to Pulmonary Vascular Leak in Sepsis in HumansPLoS Medicine, 2006
- A case–control study of bronchial asthma associated with ulcerative colitis: role of airway microvascular permeabilityClinical and Experimental Allergy, 2005
- Relationship Between Vascular Endothelial Growth Factor and Angiopoietin-2 in Asthmatics Before and After Inhaled Beclomethasone TherapyJournal of Asthma, 2005
- Functional Significance of Tie2 Signaling in the Adult VasculatureRecent Progress in Hormone Research, 2004
- Long-Acting ??2-Adrenoceptor Agonists and Exercise-Induced AsthmaPediatric Drugs, 2004
- Localized Expression of Angiopoietin 1 and 2 May Explain Unique Characteristics of the Rat Testicular MicrovasculatureBiology of Reproduction, 2003
- Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1Developmental Cell, 2002
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998